IOP Measurements Using ORA After ACXL in Keratoconus
Completed
- Conditions
- IOP Readings Before and After Accelerated Corneal Collagen Crosslinking (CXL)
- Registration Number
- NCT04464083
- Lead Sponsor
- Fayoum University
- Brief Summary
The investigators measured IOP by Goldmann applanation tonometry(GAT) before and 6 months after accelerated 8 minutes CXL in using Avedro Kxl ,and correlated with corneal resistance factor(CRF)using ORA, AC angle and CCT using Scheimpflug imaging.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- KC patient indicated for CXL
Exclusion Criteria
- Advanced KC Glaucoma patients
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine IOP readings before and after accelerated corneal collagen crosslinking April-October 2020
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does accelerated corneal collagen crosslinking (ACXL) with Avedro KXL alter corneal biomechanics and IOP measurements via ORA in keratoconus?
What are the comparative outcomes of IOP and corneal resistance factor (CRF) between accelerated and standard corneal crosslinking in keratoconus patients?
Which biomarkers correlate with sustained IOP stability after Avedro KXL ACXL in keratoconus using Scheimpflug imaging and ORA?
What are the potential adverse effects of UV-A exposure during ACXL on corneal endothelium and IOP dynamics in keratoconus?
How do riboflavin concentration and UV-A duration in ACXL influence corneal resistance and IOP measurements in keratoconus progression?
Trial Locations
- Locations (1)
Fayoum University
🇪🇬Fayoum, Egypt
Fayoum University🇪🇬Fayoum, Egypt